Results 21 to 30 of about 9,026 (213)

Experiences, Attitudes, and Knowledge within the Hemoglobinopathy Community [PDF]

open access: yes, 2022
Hemoglobinopathies are highly prevalent conditions, with a global carrier rate of about 7%, and where carriers often present with microcytic anemia. Despite this, a standard of care or treatment is not yet established for cases of hemoglobinopathies ...
Klinder, Anusha Beth
core   +1 more source

Time to Do Something for Vitamin D Deficiency; A Review

open access: yesJournal of Pediatrics Review, 2015
Context: Vitamin D deficiency is a common nutritional disorder in Iran. Vitamin D is an essential health factor from birth onward. This study was conducted to summarize epidemiologic researches regarding vitamin D deficiency in different parts of the ...
Mehrnoush Kosaryan   +3 more
doaj   +3 more sources

Hemoglobinopathy SD presenting as Hemoglobinopathy SS

open access: yesMedicina, 2017
This case report shows the interaction of hemoglobin (Hb) S with Hb D. in a child previously diagnosed with sickle cell anemia based on the Hb electrophoretic migration pattern in alkaline pH.
Sonia Maria Lissa   +4 more
doaj   +1 more source

Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials

open access: yesВопросы вирусологии, 2022
COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been ...
S. Bahadoram   +6 more
doaj   +1 more source

Early Screening of Hemoglobinopathy in Indonesia Using Erythrocyte Indices [PDF]

open access: yes, 2017
BACKGROUND: The mutation spectrums of hemoglobinopathy are different among populations that yield a different result of erythrocyte indices. Calculation of erythrocyte indices with some formula has been reported to differentiate between hemoglobinopathy ...
Yenny Surjawan   +11 more
core   +1 more source

Double heterozygocity for hemoglobin C and beta thalassemia dominant: A rare case of thalassemia intermedia

open access: yesHematology Reports, 2018
Beta thalassemia dominant results from mutations in the β globin chain gene resulting in the production of elongated, highly unstable beta globin chains.
Alexandra Agapidou   +3 more
doaj   +1 more source

Treatment Status of Patients with Β-Thalassemia Major in Northern Iran: Thalassemia Registry System

open access: yesIranian Journal of Public Health, 2019
Background: Electronic registry system of beta-thalassemia patients was run by Thalassemia Research Center (TRC) in 2017. The aim of the current study was presentation of therapeutic status in these patients at Mazandaran Province, Iran.
Mehrnoush KOSARYAN   +5 more
doaj   +1 more source

Hemoglobinopathy screening in primary care in the Netherlands: exploring the problems and needs of patients and general practitioners [PDF]

open access: yes, 2022
The prevalence of hemoglobinopathies in The Netherlands is increasing due to migration. Hemoglobinopathies are severe hereditary diseases. An informed reproductive choice by at-risk couples, such as pre-implantation diagnosis or termination of affected ...
Harteveld, C.L.   +7 more
core   +1 more source

Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?

open access: yesParasite, 2021
Background: Artemisinin-based treatment in malaria patients with abnormal hemoglobin may be ineffective because of their genetic particularity, which could lead to resistance.
Gbessi Eric A.   +10 more
doaj   +1 more source

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine

open access: yesPharmacy, 2022
Sickle-cell disease (SCD) is an inherited hemoglobinopathy, causing lifelong complications such as painful vaso-occlusive episodes, acute chest syndrome, stroke, chronic anemia, and end-organ damage, with negative effects on quality of life and life ...
Michael Migotsky   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy